Recent advances in the rational design of silica-based nanoparticles for gene therapy

Therapeutic Delivery

Volumn 3, Issue 10, 2012, Pages 1217-1237

  Niu, Yuting ^a   Popat, Amirali ^a   Yu, Meihua ^a   Karmakar, Surajit ^a   Gu, Wenyi ^a   Yu, Chengzhong ^a  

^a UNIVERSITY OF QUEENSLAND   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA 1 ANTITRYPSIN; ANTINEOPLASTIC AGENT; APTAMER; CELL PENETRATING PEPTIDE; CHIMERAPLAST; COMPLEMENTARY RNA; DOXORUBICIN; MICRORNA; MINICIRCLE DNA; MYC PROTEIN; NANOCARRIER; NANOPARTICLE; OLIGONUCLEOTIDE; PLASMA PROTEIN; PLASMID DNA; POLYMER; RIBOZYME; SILICON DIOXIDE; SMALL INTERFERING RNA; SPACER DNA; UNCLASSIFIED DRUG;

BIOCOMPATIBILITY; COMPLEX FORMATION; ENCAPSULATION; ENDOCYTOSIS; ENDOSOME; GENE SILENCING; GENE THERAPY; GENETIC ENGINEERING; HUMAN; INTERNALIZATION; MOLECULAR BEACON; NANOFABRICATION; NANOTECHNOLOGY; NANOTOXICOLOGY; NONHUMAN; NONVIRAL GENE DELIVERY SYSTEM; NUCLEAR LOCALIZATION SIGNAL; NUCLEAR PORE COMPLEX; PARTICLE SIZE; PRIORITY JOURNAL; REVIEW; SURFACE CHARGE; SURFACE PROPERTY;

EID: 84867920628     PISSN: 20415990     EISSN: 20416008     Source Type: Journal    
DOI: 10.4155/tde.12.98     Document Type: Review

References (190)

1. Anderson WF. Human gene-therapy. Science 256(5058), 808-813 (1992
2. Sokolova V, Epple M. Inorganic nanoparticles as carriers of nucleic acids into cells. Angew. Chem. Int. Ed. 47(8), 1382-1395 (2008
3. Dufes C, Uchegbu IF, Schatzlein AG. Dendrimers in gene delivery. Adv. Drug Deliv. Rev. 57(15), 2177-2202 (2005
4. Slowing II, Vivero-Escoto JL, Wu CW, Lin VSY. Mesoporous silica nanoparticles as controlled release drug delivery and gene transfection carriers. Adv. Drug Deliv. Rev. 60(11), 1278-1288 (2008
5. Mao CQ, Du JZ, Sun TM et al. A biodegradable amphiphilic and cationic triblock copolymer for the delivery of siRNA targeting the acid ceramidase gene for cancer therapy. Biomaterials 32(11), 3124-3133 (2011
6. Arnold JD, Mountain DJH, Freeman MB et al. Establishing Polymeric transfection as a non-viral, non-toxic method for gene therapy in the prevention of vascular disease. J. Vasc. Surg. 54(6), 1862-1862 (2011
7. Sedighiani F, Nikol S. Gene therapy in vascular disease. Surgeon 9(6), 326-335 (2011
8. Tuo J, Pang J-J, Cao X et al. AAV5-mediated sFLT01 gene therapy arrests retinal lesions in Ccl2/Cx3cr1 mice. Neurobiol. Aging 33(2), 433, e1-e10 (2012
9. Lieberman JR, Daluiski A, Stevenson S et al. The effect of regional gene therapy with bone morphogenetic protein-2- producing bone-marrow cells on the repair of segmental femoral defects in rats. J. Bone Joint Surg. A 81(7), 905-917 (1999
10. Wang Y, Grainger DW. RNA therapeutics targeting osteoclast-mediated excessive bone resorption. Adv. Drug Deliv. Rev. 64(12), 1341-1357 (2012
11. Morgan RA, Dudley ME, Wunderlich JR et al. Cancer regression in patients after transfer of genetically engineered lymphocytes. Science 314(5796), 126-129 (2006
12. Gaspar HB, Bjorkegren E, Parsley K et al. Successful reconstitution of immunity in ADA-SCID by stem cell gene therapy following cessation of PEG-ADA and use of mild preconditioning. Mol. Ther. 14(4), 505-513 (2006
13. Raper SE, Chirmule N, Lee FS et al. Fatal systemic inflammatory response syndrome in a ornithine transcarbamylase deficient patient following adenoviral gene transfer. Mol. Genet. Metab. 80(1-2), 148-158 (2003
14. Hacein-Bey-Abina S, Von Kalle C, Schmidt M et al. LMO2-associated clonal T cell proliferation in two patients after gene therapy for SCID-X1. Science 302(5644), 415-419 (2003
15. Fukumori Y, Ichikawa H. Nanoparticles for cancer therapy and diagnosis. Adv. Drug Deliv. Rev. 17(1), 1-28 (2006
16. Kofron MD, Laurencin CT. Bone tissue engineering by gene delivery. Adv. Drug Deliv. Rev. 58(4), 555-576 (2006
17. Cuomo F, Ceglie A, Lopez F. Specific interactions between nucleolipid doped liposomes and DNA allow a more efficient polynucleotide condensation. J. Coll. Interface Sci. 365(1), 184-190 (2012
18. Kamiya H, Fujimura Y, Matsuoka I, Harashima H. Visualization of intracellular trafficking of exogenous DNA delivered by cationic liposomes. Biochem. Biophys. Res. Commun. 298(4), 591-597 (2002
19. Zhou X, Huang L. Targeted delivery of DNA by liposomes and polymers. J. Control. Release 19(1-3), 269-274 (1992
20. Wang ZJ, Qian L, Wang XL, Yang F, Yang XR. Construction of hollow DNA/PLL microcapsule as a dual carrier for controlled delivery of DNA and drug. Coll. Surf. A Physicochem. Eng. Asp. 326(1-2), 29-36 (2008
21. Moret I, Esteban Peris J, Guillem VM et al. Stability of PEIYDNA and DOTAPYDNA complexes: Effect of alkaline pH, heparin and serum. J. Control. Release 76(1-2), 169-181 (2001
22. Navarro G, Tros De Ilarduya C. Activated and non-activated PAMAM dendrimers for gene delivery in vitro and in vivo. Nanomed. Nanotechnol. Biol. Med. 5(3), 287-297 (2009
23. Xiong X-B, Uludaǧ H, Lavasanifar A. Biodegradable amphiphilic poly(ethylene oxide)-block-polyesters with grafted polyamines as supramolecular nanocarriers for efficient siRNA delivery. Biomaterials 30(2), 242-253 (2009
24. Ye SF, Tian MM, Wang TX et al. Synergistic effects of cell-penetrating peptide Tat and fusogenic peptide HA2-enhanced cellular internalization and gene transduction of organosilica nanoparticles. Nanomedicine 8(6), 833-841 (2011
25. Adler AF, Leong KW. Emerging links between surface nanotechnology and endocytosis: Impact on nonviral gene delivery. Nano Today 5(6), 553-569 (2010
26. Mintzer MA, Simanek EE. Nonviral vectors for gene delivery. Chem. Rev. 109(2), 259-302 (2009
27. Murthy SK. Nanoparticles in modern medicine: State of the art and future challenges. Int. J. Nanomed. 2(2), 129-141 (2007
28. Maiorano G, Sabella S, Sorce B et al. Effects of cell culture media on the dynamic formation of proteinYnanoparticle complexes and influence on the cellular response. ACS Nano 4(12), 7481-7491 (2010
29. Osaki F, Kanamori T, Sando S, Sera T, Aoyama Y. A quantum dot conjugated sugar ball and its cellular uptake on the size effects of endocytosis in the subviral region. J. Am. Chem. Soc. 126(21), 6520-6521 (2004
30. Zhu Y, Meng W, Gao H, Hanagata N. hollow mesoporous silica/poly(l-lysine) particles for codelivery of drug and gene with enzyme-triggered release property. J. Phys. Chem. C 115(28), 13630-13636 (2011
31. Hartono SB, Gu WY, Kleitz F et al. Poly-l-lysine functionalized large pore cubic mesostructured silica nanoparticles as biocompatible carriers for gene delivery. ACS Nano 6(3), 2104-2117 (2012
32. Lee H, Sung D, Veerapandian M, Yun K, Seo SW. PEGylated polyethyleneimine grafted silica nanoparticles: Enhanced cellular uptake and efficient siRNA delivery. Analyt. Bioanalyt. Chem. 400(2), 535-545 (2011
33. Zhu J, Tang JW, Zhao LZ, Zhou XF, Wang YH, Yu CZ. Ultrasmall, well-dispersed, hollow siliceous spheres with enhanced endocytosis properties. Small 6(2), 276-282 (2010
34. Xia TA, Kovochich M, Liong M et al. Polyethyleneimine coating enhances the cellular uptake of mesoporous silica nanoparticles and allows safe delivery of siRNA and DNA constructs. ACS Nano 3(10), 3273-3286 (2009
35. Lin YS, Haynes CL. Impacts of mesoporous silica nanoparticle size, pore ordering, and pore integrity on hemolytic activity. J. Am. Chem. Soc. 132(13), 4834-4842 (2010
36. Zhu Y, Fang Y, Borchardt L, Kaskel S. PEGylated hollow mesoporous silica nanoparticles as potential drug delivery vehicles. Microporous Mesoporous Mater. 141(1-3), 199-206 (2011
37. García-Calzón JA, Díaz-García ME. Synthesis and analytical potential of silica nanotubes. Trends Analyt. Chem. 35, 27-38 (2012
38. Ashley CE, Carnes EC, Phillips GK et al. The targeted delivery of multicomponent cargos to cancer cells by nanoporous particle-supported lipid bilayers Nat. Mater. 10(6), 476-476 (2011
39. Pedram EO, Hines AL. Pure vapor adsorption of water on mobil sorbead-R silica-gel. J. Chem. Eng. Data 28(1), 11-14 (1983
40. Ryoo R. Porous materials A tricontinuous mesoporous system. Nat. Chem. 1(2), 105-106 (2009
41. Zhao DY, Feng JL, Huo QS et al. Triblock copolymer syntheses of mesoporous silica with periodic 50 to 300 angstrom pores. Science 279(5350), 548-552 (1998
42. Kresge CT, Leonowicz ME, Roth WJ, Vartuli JC, Beck JS. Ordered mesoporous molecular-sieves synthesized by a liquid-crystal template mechanism. Nature 359(6397), 710-712 (1992
43. Stober W, Fink A, Bohn E. Controlled growth of monodisperse silica spheres in micron size range. J. Coll. Interface Sci. 26(1), 62-69 (1968
44. He XX, Wang KM, Tan WH et al. Bioconjugated nanoparticles for DNA protection from cleavage. J. Am. Chem. Soc. 125(24), 7168-7169 (2003
45. Slowing II, Vivero-Escoto JL, Wu C-W, Lin VSY. Mesoporous silica nanoparticles as controlled release drug delivery and gene transfection carriers. Adv. Drug Deliv. Rev. 60(11), 1278-1288 (2008
46. Xie J, Lee S, Chen X. Nanoparticle-based theranostic agents. Adv. Drug Deliv. Rev. 62(11), 1064-1079 (2010
47. Dolatabadi JEN, De La Guardia M. Applications of diatoms and silica nanotechnology in biosensing, drug and gene delivery, and formation of complex metal nanostructures. Trends Analyt. Chem. 30(9), 1538-1548 (2011
48. Popat A, Hartono SB, Stahr F, Liu J, Qiao SZ, Lu GQ. Mesoporous silica nanoparticles for bioadsorption, enzyme immobilisation, and delivery carriers. Nanoscale 3(7), 2801-2818 (2011
49. Popat A, Liu J, Lu GQ, Qiao SZ. A pH-responsive drug delivery system based on chitosan coated mesoporous silica nanoparticles. J. Mater. Chem. 22(22), 11173-11178 (2012
50. Livingston DM. Inheritance of the 2 micrometer m DNA plasmid from Saccharomyces. Genetics 86(1), 73-84 (1977
51. Shi FS, Rakhmilevich AL, Heise CP et al. Intratumoral injection of interleukin-12 plasmid DNA, either naked or in complex with cationic lipid, results in similar tumor regression in a murine model. Mol. Cancer Ther. 1(11), 949-957 (2002
52. Vivero-Escoto JL, Slowing II, Lin VSY. Tuning the cellular uptake and cytotoxicity properties of oligonucleotide intercalator-functionalized mesoporous silica nanoparticles with human cervical cancer cells HeLa. Biomaterials 31(6), 1325-1333 (2010
53. Jung MR, Shim IK, Kim ES et al. Controlled release of cell-permeable gene complex from poly(l-lactide) scaffold for enhanced stem cell tissue engineering. J. Control. Release 152(2), 294-302 (2011
54. Anderson RJ, Schneider J. Plasmid DNA and viral vector-based vaccines for the treatment of cancer. Vaccine 25(Suppl. 2), B24YB34 (2007
55. Suwalski A, Dabboue H, Delalande A et al. Accelerated Achilles tendon healing by PDGF gene delivery with mesoporous silica nanoparticles. Biomaterials 31(19), 5237-5245 (2010
56. Darquet AM, Cameron B, Wils P, Scherman D, Crouzet J. A new DNA vehicle for nonviral gene delivery: Supercoiled minicircle. Gene Ther. 4(12), 1341-1349 (1997
57. Park JH, Lee M, Kim SW. Non-viral adiponectin gene therapy into obese 2 type diabetic mice ameliorates insulin resistance. J. Control. Release 114(1), 118-125 (2006
58. Van Gaal EVB, Oosting RS, Hennink WE, Crommelin DJA, Mastrobattista E. Junk DNA enhances pEI-based non-viral gene delivery. Int. J. Pharm. 390(1), 76-83 (2010
59. Fedor MJ. Structure and function of the hairpin ribozyme. J. Mol. Biol. 297(2), 269-291 (2000
60. Scott WG, Finch JT, Klug A. The crystal structure of an AII-RNAhammerhead ribozyme: A proposed mechanism for RNA catalytic cleavage. Cell 81(7), 991-1002 (1995
61. Pley HW, Flaherty KM, Mckay DB. Three-dimensional structure of a hammerhead ribozyme. Nature 372(6501), 68-74 (1994
62. Kolniak TA, Sullivan JM. Rapid, cell-based toxicity screen of potentially therapeutic post-transcriptional gene silencing agents. Exp. Eye Res. 92(5), 328-337 (2011
63. Ozaki I, Zern MA, Liu S, Wei DL, Pomerantz RJ, Duan L. Ribozyme-mediated specific gene replacement of the a1-antitrypsin gene in human hepatoma cells. J. Hepatol. 31(1), 53-60 (1999
64. Uhlmann E, Peyman A. Antisense oligonucleotides: A new therapeutic principle. Chem. Rev. 90(4), 543-584 (1990
65. Stein C, Cheng Y. Antisense oligonucleotides as therapeutic agents Y is the bullet really magical? Science 261(5124), 1004-1012 (1993
66. Su W-Y, Xiong H, Fang J-Y. Natural antisense transcripts regulate gene expression in an epigenetic manner. Biochem. Biophys. Res. Commun. 396(2), 177-181 (2010
67. Hamada K, Shirakawa T, Gotoh A, Roth JA, Follen M. Adenovirus-mediated transfer of human papillomavirus 16 E6/E7 antisense RNA and induction of apoptosis in cervical cancer. Gynecol. Oncol. 103(3), 820-830 (2006
68. Bock LC, Griffin LC, Latham JA, Vermaas EH, Toole JJ. Selection of single-stranded- DNA molecules that bind and inhibit human thrombin. Nature 355(6360), 564-566 (1992
69. Huizenga DE, Szostak JW. A DNA Aptamer that binds adenosine and ATP. Biochemistry 34(2), 656-665 (1995
70. Guo PX, Coban O, Snead NM et al. Engineering RNA for targeted siRNA delivery and medical application. Adv. Drug Deliv. Rev. 62(6), 650-666 (2010
71. Hermann T, Patel DJ. Biochemistry Y adaptive recognition by nucleic acid aptamers. Science 287(5454), 820-825 (2000
72. Nimjee SM, Rusconi CP, Sullenger BA. Aptamers: An emerging class of therapeutics. Annu. Rev. Med. 56, 555-583 (2005
73. Farokhzad OC, Cheng JJ, Teply BA et al. Targeted nanoparticle-aptamer bioconjugates for cancer chemotherapy in vivo. Proc. Natl Acad. Sci. USA 103(16), 6315-6320 (2006
74. Zhang S, Zhao Y, Zhi D, Zhang S. Non-viral vectors for the mediation of RNAi. Bioorg. Chem. 40, 10-18 (2012
75. Hartono SB, Gu W, Kleitz F et al. Poly-l-lysine functionalized large pore cubic mesostructured silica nanoparticles as biocompatible carriers for gene delivery. ACS Nano 6(3), 2104-2117 (2012
76. Fire A, Xu SQ, Montgomery MK, Kostas SA, Driver SE, Mello CC. Potent and specific genetic interference by double-stranded RNA in Caenorhabditis elegans. Nature 391(6669), 806-811 (1998
77. Mao C-Q, Du J-Z, Sun T-M et al. A biodegradable amphiphilic and cationic triblock copolymer for the delivery of siRNA targeting the acid ceramidase gene for cancer therapy. Biomaterials 32(11), 3124-3133 (2011
78. Kim JK, Choi KJ, Lee M, Jo MH, Kim S. Molecular imaging of a cancer-targeting theragnostics probe using a nucleolin aptamer-and microRNA-221 molecular beacon-conjugated nanoparticle. Biomaterials 33(1), 207-217 (2012
79. Rando TA. Oligonucleotide-mediated gene therapy for muscular dystrophies. Neuromusc. Disord. 12, S55YS60 (2002
80. Graham IR, Dickson G. Gene repair and mutagenesis mediated by chimeric RNA-DNA oligonucleotides: Chimeraplasty for gene therapy and conversion of single nucleotide polymorphisms (SNPs). Biochim. Biophys. Acta 1587(1), 1-6 (2002
81. Li Z-H, Liu D-P, Yin W-X, Guo Z-C, Liang C-C. Targeted correction of the point mutations of b-thalassemia and targeted mutagenesis of the nucleotide associated with HPFH by RNA/DNA oligonucleotides: Potential for b-thalassemia gene therapy. Blood Cell. Mol. Dis. 27(2), 530-538 (2001
82. Ferreira GNM, Monteiro GA, Prazeres DMF, Cabral JMS. Downstream processing of plasmid DNA for gene therapy and DNA vaccine applications. Trends Biotechnol. 18(9), 380-388 (2000
83. Minigo G, Scholzen A, Tang CK et al. Poly-l-lysine-coated nanoparticles: A potent delivery system to enhance DNA vaccine efficacy. Vaccine 25(7), 1316-1327 (2007
84. Veiseh O, Kievit FM, Mok H et al. Cell transcytosing poly-arginine coated magnetic nanovector for safe and effective siRNA delivery. Biomaterials 32(24), 5717-5725 (2011
85. Burnett JC, Rossi JJ. RNA-based therapeutics: Current progress and future prospects. Chem. Biol. 19(1), 60-71 (2012
86. Zuker M. On Finding all suboptimal foldings of an RNA Molecule. Science 244(4900), 48-52 (1989
87. Correll CC, Freeborn B, Moore PB, Steitz TA. Metals, motifs, and recognition in the crystal structure of a 5S rRNA domain. Cell 91(5), 705-712 (1997
88. Pleij CWA, Bosch L. RNA pseudoknots Y structure, detection, and prediction. Methods Enzymol. 180, 289-303 (1989
89. Jaeger JA, Santalucia J, Tinoco I. Determination of RNA structure and thermodynamics. Annu. Rev. Biochem. 62, 255-287 (1993
90. Kaneko H, Suzuki H, Abe T, Miyano- Kurosaki N, Takaku H. Inhibition of HIV-1 replication by vesicular stomatitis virus envelope glycoprotein pseudotyped baculovirus vector-transduced ribozyme in mammalian cells. Biochem. Biophy. Res. Commun. 349(4), 1220-1227 (2006
91. Zhu SG, Xiang JJ, Li XL et al. Poly(l-lysine)- modified silica nanoparticles for the delivery of antisense oligonucleotides. Biotechnol. Appl. Biochem. 39, 179-187 (2004
92. Barnor JS, Miyano-Kurosaki N, Yamaguchi K et al. Intracellular expression of antisense RNA transcripts complementary to the human immunodeficiency virus type-1 vif gene inhibits viral replication in infected T-lymphoblastoid cells. Biochem. Biophys. Res. Commun. 320(2), 544-550 (2004
93. Que-Gewirth NS, Sullenger BA. Gene therapy progress and prospects: RNA aptamers. Gene Ther. 14(4), 283-291 (2007
94. Martell RE, Nevins JR, Sullenger BA. Optimizing aptamer activity for gene therapy applications using expression cassette SELEX. Mol. Ther. 6(1), 30-34 (2002
95. Ishizaki J, Nevins JR, Sullenger BA. Inhibition of cell proliferation by an RNA ligand that selectively blocks E2F function. Nat. Med. 2(12), 1386-1389 (1996
96. Nana-Sinkam SP, Croce CM. MicroRNAs as therapeutic targets in cancer. Transl. Res. 157(4), 216-225 (2011
97. Ashley CE, Carnes EC, Epler KE et al. Delivery of small interfering RNA by peptide-targeted mesoporous silica nanoparticle-supported lipid bilayers. ACS Nano 6(3), 2174-2188 (2012
98. Tagalakis AD, Owen JS, Simons JP. Lack of RNAYDNA oligonucleotide (chimeraplast) mutagenic activity in mouse embryos. Mol. Reprod. Develop. 71(2), 140-144 (2005
99. Xiang S, Tong H, Shi Q et al. Uptake mechanisms of non-viral gene delivery. J. Control. Release 158(3), 371-378 (2012
100. Van Der Aa MA, Huth US, Hafele SY et al. Cellular uptake of cationic polymerYDNA complexes via caveolae plays a pivotal role in gene transfection in COS-7 cells. Pharm. Res. 24(8), 1590-1598 (2007
101. Vibin M, Vinayakan R, John A, Rejiya CS, Raji V, Abraham A. Cellular uptake and subcellular localization of highly luminescent silica-coated CdSe quantum dots Y in vitro and in vivo. J. Coll. Interface Sci. 357(2), 366-371 (2011
102. Shen SD, Gu T, Mao DS et al. Synthesis of nonspherical mesoporous silica ellipsoids with tunable aspect ratios for magnetic assisted assembly and gene delivery. Chem. Mater. 24(1), 230-235 (2012
103. Park IY, Kim IY, Yoo MK, Choi YJ, Cho MH, Cho CS. Mannosylated polyethylenimine coupled mesoporous silica nanoparticles for receptor-mediated gene delivery. Int. J. Pharm. 359(1-2), 280-287 (2008
104. Slowing I, Trewyn BG, Lin VSY. Effect of surface functionalization of MCM-41-type mesoporous silica nanoparticleson the endocytosis by human cancer cells. J. Am. Chem. Soc. 128(46), 14792-14793 (2006
105. Chung TH, Wu SH, Yao M et al. The effect of surface charge on the uptake and biological function of mesoporous silica nanoparticles 3T3-L1 cells and human mesenchymal stem cells. Biomaterials 28(19), 2959-2966 (2007
106. Slowing II, Wu CW, Vivero-Escoto JL, Lin VSY. Mesoporous silica nanoparticles for reducing hemolytic activity towards mammalian red blood cells. Small 5(1), 57-62 (2009
107. Xu Z, Wang SL, Gao HW. Effects of nano-sized silicon dioxide on the structures and activities of three functional proteins. J. Hazard. Mater. 180(1-3), 375-383 (2010
108. Shi J, Hedberg Y, Lundin M, Odnevall Wallinder I, Karlsson HL, Möller L. Hemolytic properties of synthetic nano- and porous silica particles: The effect of surface properties and the protection by the plasma corona. Acta Biomater. 8(9), 3478-3490 (2012
109. Yiu HHP, Mcbain SC, Lethbridge ZaD, Lees MR, Dobson J. Preparation and characterization of polyethylenimine-coated Fe3O4-MCM-48 nanocomposite particles as a novel agent for magnet-assisted transfection. J. Biomed. Mater. Res. A 92A(1), 386-392 (2010
110. Zhang X, Ma GH, Su ZG, Benkirane-Jessel N. Novel poly(l-lysine) particles for gene delivery. J. Control. Release 152, E182YE184 (2011
111. Miyata K, Gouda N, Takemoto H et al. Enhanced transfection with silica-coated polyplexes loading plasmid DNA. Biomaterials 31(17), 4764-4770 (2010
112. Khalil IA, Kogure K, Futaki S et al. Octaarginine-modified multifunctional envelope-type nanoparticles for gene delivery. Gene Ther. 14(8), 682-689 (2007
113. He QJ, Zhang JM, Shi JL et al. The effect of PEGylation of mesoporous silica nanoparticles on nonspecific binding of serum proteins and cellular responses. Biomaterials 31(6), 1085-1092 (2010
114. Radu DR, Lai CY, Jeftinija K, Rowe EW, Jeftinija S, Lin VSY. A polyamidoamine dendrimer-capped mesoporous silica nanosphere-based gene transfection reagent. J. Am. Chem. Soc. 126(41), 13216-13217 (2004
115. Zeng P, Xu Y, Zeng CH, Ren H, Peng ML. Chitosan-modified poly(d,l-lactide-co-glycolide) nanospheres for plasmid DNA delivery and HBV gene-silencing. Int. J. Pharm. 415(1-2), 259-266 (2011
116. Angelopoulou A, Efthimiadou EK, Kordas G. Dextran modified pH sensitive silica hydro-xerogels as promising drug delivery scaffolds. Mater. Lett. 74, 50-53 (2012
117. Kunzmann A, Andersson B, Vogt C et al. Efficient internalization of silica-coated iron oxide nanoparticl es of different sizes by primary human macrophages and dendritic cells. Toxicol. Appl. Pharm. 253(2), 81-93 (2011
118. Chen AM, Zhang M, Wei DG et al. Co-delivery of doxorubicin and Bcl-2 siRNA by mesoporous silica nanoparticles enhances the efficacy of chemotherapy in multidrug-resistant cancer cells. Small 5(23), 2673-2677 (2009
119. Meng HA, Liong M, Xia TA et al. Engineered design of mesoporous silica nanoparticles to deliver doxorubicin and P-glycoprotein siRNA to overcome drug resistance in a cancer cell line. ACS Nano 4(8), 4539-4550 (2010
120. Cermenati G, Terracciano I, Castelli I et al. The CPP Tat enhances eGFP cell internalization and transepithelial transport by the larval midgut of bombyx mori (lepidoptera, bombycidae). J. Insect Physiol. 57(12), 1689-1697 (2011
121. Fonseca SB, Pereira MP, Kelley SO. Recent advances in the use of cell-penetrating peptides for medical and biological applications. Adv. Drug Deliv. Rev. 61(11), 953-964 (2009
122. Gao CB, Izquierdo-Barba I, Nakase I et al. Mesostructured silica based delivery system for a drug with a peptide as a cell-penetrating vector. Microporous Mesoporous Mater. 122(1-3), 201-207 (2009
123. Ziegler A, Nervi P, Durrenberger M, Seelig J. The cationic cell-penetrating peptide CPP(TAT) derived from the HIV-1 protein TAT is rapidly transported into living fibroblasts: optical, biophysical, and metabolic evidence. Biochemistry 44(1), 138-148 (2005
124. Mao Z, Wan L, Hu L, Ma L, Gao C. Tat peptide mediated cellular uptake of SiO2 submicron particles. Coll. Surf. B Biointerfaces 75(2), 432-440 (2010
125. Moore NM, Sheppard CL, Barbour TR, Sakiyama-Elbert SE. The effect of endosomal escape peptides on in vitro gene delivery of polyethylene glycol-based vehicles. J. Gene Med. 10(10), 1134-1149 (2008
126. Oliveira S, Van Rooy I, Kranenburg O, Storm G, Schiffelers RM. Fusogenic peptides enhance endosomal escape improving siRNA-induced silencing of oncogenes. Int. J. Pharm. 331(2), 211-214 (2007
127. Sadeghian F, Hosseinkhani S, Alizadeh A, Hatefi A. Design, engineering and preparation of a multi-domain fusion vector for gene delivery. Int. J. Pharma 427(2), 393-399 (2012
128. Varkouhi AK, Scholte M, Storm G, Haisma HJ. Endosomal escape pathways for delivery of biologicals. J. Control. Release 151(3), 220-228 (2011
129. Canton I, Battaglia G. Endocytosis at the nanoscale. Chem. Soc. Rev. 41(7), 2718-2739 (2012
130. Sauer AM, Schlossbauer A, Ruthardt N, Cauda V, Bein T, Brauchle C. Role of endosomal escape for disulfide-based drug delivery from colloidal mesoporous silica evaluated by live-cell imaging. Nano Lett. 10(9), 3684-3691 (2010
131. Chang JH, Kim KJ, Shin YK. Sustained drug release on temperature- responsive polymer hybrid nanoporous silica composites. Bull. Korean Chem. Soc. 25(8), 1257-1260 (2004
132. Chen F, Zhu Y. Chitosan enclosed mesoporous silica nanoparticles as drug nano-carriers: Sensitive response to the narrow pH range. Microporous Mesoporous Mater. 150(0), 83-89 (2012
133. Xu Y, Qu F, Wang Y, Lin H, Wu X, Jin Y. Construction of a novel pH-sensitive drug release system from mesoporous silica tablets coated with Eudragit. Solid State Sci. 13(3), 641-646 (2011
134. van der Aa Ma, Mastrobattista E, Oosting RS, Hennink WE, Koning GA, Crommelin DJA. The nuclear pore complex: The gateway to successful nonviral gene delivery. Pharm. Res. 23(3), 447-459 (2006
135. Pan L, He Q, Liu J et al. Nuclear-targeted drug delivery of TAT peptide-conjugated monodisperse mesoporous silica nanoparticles. J. Am. Chem. Soc. 134(13), 5722-5725 (2012
136. Zhang JX, Sun W, Bergman L et al. Magnetic mesoporous silica nanospheres as DNA/drug carrier. Mater. Lett. 67(1), 379-382 (2012
137. Liu J, Wang B, Hartono SB et al. Magnetic silica spheres with large nanopores for nucleic acid adsorption and cellular uptake. Biomaterials 33(3), 970-978 (2012
138. Yiu HHP, Mcbain SC, Lethbridge ZaD, Lees MR, Dobson J. Preparation and characterization of polyethylenimine-coated Fe3O4-MCM-48 nanocomposite particles as a novel agent for magnet-assisted transfection. J. Biomed. Mater. Res. A 92A(1), 386-392 (2010
139. Medintz IL, Uyeda HT, Goldman ER, Mattoussi H. Quantum dot bioconjugates for imaging, labelling and sensing. Nat. Mater. 4(6), 435-446 (2005
140. Michalet X, Pinaud FF, Bentolila LA et al. Quantum dots for live cells, in vivo imaging, and diagnostics. Science 307(5709), 538-544 (2005
141. Wu C-S, Oo MKK, Cupps JM, Fan X. Robust silica-coated quantum dotYmolecular beacon for highly sensitive DNA detection. Biosens. Bioelectron. 26(9), 3870-3875 (2011
142. Christen V, Fent K. Silica nanoparticles and silver-doped silica nanoparticles induce endoplasmatic reticulum stress response and alter cytochrome P4501A activity. Chemosphere 87(4), 423-434 (2012
143. Liu SH, Zhang ZH, Wang YB, Wang FK, Han MY. Surface-functionalized silica-coated gold nanoparticles and their bioapplications. Talanta 67(3), 456-461 (2005
144. Witasp E, Kupferschmidt N, Bengtsson L et al. Efficient internalization of mesoporous silica particles of different sizes by primary human macrophages without impairment of macrophage clearance of apoptotic or antibody-opsonized target cells. Toxicol. Appl. Pharm. 239(3), 306-319 (2009
145. Russo PA, Carrott MMLR, Mourao PAM, Carrott PJM. Tailoring the surface chemistry of mesocellular foams for protein adsorption. Coll. Surf. A Physicochem. Eng. Asp. 386(1-3), 25-35 (2011
146. Drescher D, Orts-Gil G, Laube G et al. Toxicity of amorphous silica nanoparticles on eukaryotic cell model is determined by particle agglomeration and serum protein adsorption effects. Analyt. Bioanalyt. Chem. 400(5), 1367-1373 (2011
147. Kim J, Kim HS, Lee N et al. Multifunctional uniform nanoparticles composed of a magnetite nanocrystal core and a mesoporous silica shell for magnetic resonance and fluorescence imaging and for drug delivery. Angew. Chem. Int. Ed. 47(44), 8438-8441 (2008
148. Ogris M, Brunner S, Schuller S, Kircheis R, Wagner E. PEGylated DNA/transferrin-PEI complexes: Reduced interaction with blood components, extended circulation in blood and potential for systemic gene delivery. Gene Therapy 6(4), 595-605 (1999
149. Lu F, Wu SH, Hung Y, Mou CY. Size effect on cell uptake in well-suspended, uniform mesoporous silica nanoparticles. Small 5(12), 1408-1413 (2009
150. Chithrani BD, Ghazani AA, Chan WCW. Determining the size and shape dependence of gold nanoparticle uptake into mammalian cells. Nano Lett. 6(4), 662-668 (2006
151. Li Y, Sun L, Jin MH et al. Size-dependent cytotoxicity of amorphous silica nanoparticles in human hepatoma HepG2 cells. Toxicol. Vitro 25(7), 1343-1352 (2011
152. Chono S, Tanino T, Seki T, Morimoto K. Uptake characteristics of liposomes by rat alveolar macrophages: Influence of particle size and surface mannose modification. J. Pharm. Pharmacol. 59(1), 75-80 (2007
153. Lai SK, Hida K, Man ST et al. Privileged delivery of polymer nanoparticles to the perinuclear region of live cells via a non-clathrin, non-degradative pathway. Biomaterials 28(18), 2876-2884 (2007
154. Jiang W, Kim BYS, Rutka JT, Chan WCW. Nanoparticle-mediated cellular response is size-dependent. Nat. Nanotechnol. 3(3), 145-150 (2008
155. Guo J, Bourre L, Soden DM, O'sullivan GC, O'driscoll C. Can non-viral technologies knockdown the barriers to siRNA delivery and achieve the next generation of cancer therapeutics? Biotechnol. Adv. 29(4), 402-417 (2011
156. Rai P, Mallidi S, Zheng X et al. Development and applications of photo-triggered theranostic agents. Adv. Drug Deliv. Rev. 62(11), 1094-1124 (2010
157. Zhao YN, Sun XX, Zhang GN, Trewyn BG, Slowing II, Lin VSY. Interaction of mesoporous silica nanoparticles with human red blood cell membranes: Size and surface effects. ACS Nano 5(2), 1366-1375 (2011
158. Liu F, Yua P, Wan JJ et al. Periodic mesoporous organosilicas with controlled pore symmetries for peptides enrichment. J. Nanosci. Nanotechnol. 11(6), 5215-5222 (2011
159. Huang L, Kruk M. Synthesis of ultra-large-pore FDU-12 silica using ethylbenzene as micelle expander. J. Coll. Interface Sci. 365(1), 137-142 (2012
160. Wang HN, Zhou XF, Yu MH et al. Supra-assembly of siliceous vesicles. J. Am. Chem. Soc. 128(50), 15992-15993 (2006
161. Suteewong T, Sai H, Cohen R et al. Highly aminated mesoporous silica nanoparticles with cubic pore structure. J. Am. Chem. Soc. 133(2), 172-175 (2011
162. Huang XL, Teng X, Chen D, Tang FQ, He JQ. The effect of the shape of mesoporous silica nanoparticles on cellular uptake and cell function. Biomaterials 31(3), 438-448 (2010
163. Huang XL, Li LL, Liu TL et al. The shape Effect of mesoporous silica nanoparticles on biodistribution, clearance, and biocompatibility in vivo. ACS Nano 5(7), 5390-5399 (2011
164. Jankiewicz BJ, Jamiola D, Choma J, Jaroniec M. Silica-metal core-shell nanostructures. Adv. Coll. Interface Sci. 170(1-2), 28-47 (2012
165. Jo C, Kim K, Ryoo R. Syntheses of high quality KIT-6 and SBA-15 mesoporous silicas using low-cost water glass, through rapid quenching of silicate structure in acidic solution. Microporous Mesoporous Mater. 124(1-3), 45-51 (2009
166. Liu S, Lu L, Yang Z, Cool P, Vansant EF. Further investigations on the modified Stöber method for spherical MCM-41. Mater. Chem. Phys. 97(2-3), 203-206 (2006
167. Kruk M, Hui CM. Synthesis and characterization of large-pore FDU-12 silica. Microporous Mesoporous Mater. 114(1-3), 64-73 (2008
168. Fantini MCA, Kanagussuko CF, Zilioti GJM, Martins TS. Synthesis and structure of cage-like mesoporous silica using different precursors. J. Alloys Compounds 509, S357YS360 (2011
169. Parambadath S, Rana VK, Moorthy S et al. Periodic mesoporous organosilicas with co-existence of diurea and sulfanilamide as an effective drug delivery carrier. J. Solid State Chem. 184(5), 1208-1215 (2011
170. Shin JH, Park SS, Selvaraj M, Ha CS. Adsorption of amino acids on periodic mesoporous organosilicas. J. Porous Mater. 19(1), 29-35 (2012
171. He QJ, Shi JL. Mesoporous silica nanoparticle based nano drug delivery systems: Synthesis, controlled drug release and delivery, pharmacokinetics and biocompatibility. J. Mater. Chem. 21(16), 5845-5855 (2011
172. Park DH, Nishiyama N, Egashira Y, Ueyama K. Separation of organic/water mixtures with silylated MCM-48 silica membranes. Microporous and Mesoporous Materials 66(1), 69-76 (2003
173. Fenelonov VB, Romannikov VN, Derevyankin AL. Mesopore size and surface area calculations for hexagonal mesophases (types MCM41, FSM-16, etc.) using low-angle XRD and adsorption data. Microporous Mesoporous Mater. 28(1), 57-72 (1999
174. Bhattarai SR, Muthuswamy E, Wani A et al. Enhanced gene and siRNA delivery by polycation-modified mesoporous silica nanoparticles loaded with chloroquine. Pharm. Res. 27(12), 2556-2568 (2010
175. Deng Z, Zhen Z, Hu X, Wu S, Xu Z, Chu PK. Hollow chitosanYsilica nanospheres as pH-sensitive targeted delivery carriers in breast cancer therapy. Biomaterials 32(21), 4976-4986 (2011
176. Na H-K, Kim M-H, Park K et al. Efficient functional delivery of siRNA using mesoporous silica nanoparticles with ultralarge pores. Small 8(11), 1752-1761 (2012
177. Kim MH, Na HK, Kim YK et al. Facile synthesis of monodispersed mesoporous silica nanoparticles with ultralarge pores and their application in gene delivery. ACS Nano 5(5), 3568-3576 (2011
178. Lee HI, Kim JH, Stucky GD, Shi YF, Pak C, Kim JM. Morphology-selective synthesis of mesoporous SBA-15 particles over micrometer, submicrometer and nanometer scales. J. Mater. Chem. 20(39), 8483-8487 (2010
179. Sun J, Zhang H, Tian R et al. Ultrafast enzyme immobilization over large-pore nanoscale mesoporous silica particles. Chem. Commun. (12), 1322-1324 (2006
180. Ji X, Lee KT, Monjauze M, Nazar LF. Strategic synthesis of SBA-15 nanorods. Chem. Commun. (36), 4288-4290 (2008
181. Wagner CS, Shehata S, Henzler K, Yuan JY, Wittemann A. Towards nanoscale composite particles of dual complexity. J. Coll. Interface Sci. 355(1), 115-123 (2011
182. Chen CC, Liu YC, Wu CH, Yeh CC, Su MT, Wu YC. Preparation of fluorescent silica nanotubes and their application in gene delivery. Adv. Mater. 17(4), 404-407 (2005
183. Bhushan B, Jung YC. Natural and biomimetic artificial surfaces for superhydrophobicity, self-cleaning, low adhesion, and drag reduction. Prog. Mater. Sci. 56(1), 1-108 (2011
184. Nel AE, Madler L, Velegol D et al. Understanding biophysicochemical interactions at the nano-bio interface. Nat. Mater. 8(7), 543-557 (2009
185. Liu XM, He JH. Hierarchically structured superhydrophilic coatings fabricated by self-assembling raspberry-like silica nanospheres. J. Coll. Interface Sci. 314(1), 341-345 (2007
186. Trewyn BG, Nieweg JA, Zhao Y, Lin VSY. Biocompatible mesoporous silica nanoparticles with different morphologies for animal cell membrane, penetration. Chem. Eng. J. 137(1), 23-29 (2008
187. Parker AL, Eckley L, Singh S, Preece JA, Collins L, Fabre JW. (LYS)16-based reducible polycations provide stable polyplexes with anionic fusogenic peptides and efficient gene delivery to post mitotic cells. Biochim. Biophys. Acta 1770(9), 1331-1337 (2007
188. Lee SH, Kim SH, Park TG. Intracellular siRNA delivery system using polyelectrolyte complex micelles prepared from VEGF siRNA-PEG conjugate and cationic fusogenic peptide. Biochem. Biophys. Res. Commun. 357(2), 511-516 (2007
189. Pichon C, Gonçalves C, Midoux P. Histidine-rich peptides and polymers for nucleic acids delivery. Adv. Drug Deliv. Rev. 53(1), 75-94 (2001
190. Bardi G, Malvindi MA, Gherardini L et al. The biocompatibility of amino functionalized CdSe/ZnS quantum-dot-Doped SiO2 nanoparticles with primary neural cells and their gene carrying performance. Biomaterials 31(25), 6555-6566 (2010